MoneyWorks4Me

GlaxoSmithKline Pharmaceuticals board will consider financial results

01 Aug 2012 Evaluate
GlaxoSmithKline Pharmaceuticals has informed that a meeting of the board of directors of the company will be held on August 13, 2012, to consider unaudited financial results for the quarter April - June 2012 (Q2) and half year January - June 2012.

The above information is a part of company's filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1783.25
Dr. Reddys Labs. 1202.40
Cipla 1329.50
Lupin 2007.10
Zydus Lifesciences 1154.00
View more..